Immune checkpoint inhibitors–induced large vessel vasculitis: clinical characteristics and management from a European multicentre study

ICI-induced LVV is a rare, early-onset IrAE. Although continuation of ICIs may affect LVV outcomes, cancer progression remains the primary cause of mortality. Prospective studies are warranted to better balance therapeutic approaches.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-03-26
DOI
https://doi.org/10.1093/rheumatology/keaf172
Citations
3
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune checkpoint inhibitors–induced large vessel vasculitis: clinical characteristics and management from a European multicentre study

R. Outh, Louis Wolff, G. Armengol, Eva Bories et al.
3 citations
Lara D. Veeken
Vasculitis and related conditions
4.56
article

Immune checkpoint inhibitors–induced large vessel vasculitis: clinical characteristics and management from a European multicentre study

R. Outh, Louis Wolff, G. Armengol, Eva Bories, Albrecht Betrains, LARISSA ALMEIDA CAMPOS ESTEVES, Laure Delaval, Lorenzo Dagna, Patrick Bruneval, Alexandra Forestier, Alessandro Tomelleri, Adrien Cottu, Corrado Campochiaro, Xavier Savary, Aline Gury, Milena Bond, Laurence Bouillet, Ariane Laparra, Jérémie Dion, Paul Legendre, Omar Al Tabaa, Philippe Kerschen, Benjamin Crichi, Arthur Petitdemange, Maxime Ilzkovitz, Benjamin Terrier, Eric Liozon, Robin Dhôte, Mohammad Yassine Chérif
article en
3 citations

Abstract

ICI-induced LVV is a rare, early-onset IrAE. Although continuation of ICIs may affect LVV outcomes, cancer progression remains the primary cause of mortality. Prospective studies are warranted to better balance therapeutic approaches.

Lara D. VeekenVol. 64(8)
Institut polytechnique de Grenoble (FR), Centre National de la Recherche Scientifique (FR), Université Libre de Bruxelles (BE), Vita-Salute San Raffaele University (IT), Centre Hospitalier de Luxembourg (LU), Université Paris Cité (FR), Centre Hospitalier Universitaire de Grenoble (FR), Institut Gustave Roussy (FR), Erasmus Hospital (BE), Centre Hospitalier de Perpignan (FR), Sorbonne Paris Cité (FR), Pathways Behavioral Services (US), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), Institut universitaire du cancer de Toulouse Oncopole (FR), Hôpital Européen Georges-Pompidou (FR), VetAgro Sup (FR), Clinique Saint-Joseph (BE), Centre Hospitalier du Mans (FR), Hôpital Avicenne (FR), Centre Oscar Lambret (FR), Centre Hospitalier Régional Universitaire de Brest (FR), BP (France) (FR), Centre Hospitalier d'Arras (FR), Hôpital Purpan (FR), Hôpital Saint-Louis (FR), Centre Hospitalier Saint-Denis (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Centre Hospitalier Universitaire de Saint-Étienne (FR), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Université de Limoges (FR), Université Grenoble Alpes (FR), KU Leuven (BE)
Good health and well-being
Openalex Percentile: Top 6%
Vasculitis and related conditions
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.